FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2022
Voltar para busca
Dado oficial do USPTO
VIVINEX IMPRESS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VIVINEX IMPRESS
ST13
US500000079275719Classe
5, 9, 10
Pedido
79275719
Registro
6571251
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
21/04/2023
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
10/10/2019
Data de registro
30/11/2021
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/11/2021
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
Singapore, SG
Examinador
LIU, PHILIP
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
HOYA MEDICAL SINGAPORE PTE. LTD.
Representantes
JAMES A. HENRICKS HENRICKS SLAVIN LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparationspharmaceutical and veterinary preparations for surgical implantation of intraocular lenses; sanitary preparations for medical purposes; materials for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; medicated eye wash for pharmaceutical purposes; chemical preparations for medical purposesbiological preparations for medical purposes in the nature of eye lubricantsviscoelastic agents for ophthalmic purposes and eye washes; chemical compositions for medical purposespharmaceutical and veterinary preparations for use in cataract surgery and intraocular and intraocular lens implant surgical procedures; solutions for contact lenses and for intraocular lenses; all of the foregoing excluding dietetic substances adapted for medical use and food for babies
Classe 9
Scientificnauticalsurveyingphotographiccinematographicopticalweighingmeasuringsignalingchecking and supervisionlife-saving and teaching apparatus and instrumentssurveyingcinematographicweighingoptical apparatus and instruments; apparatus for recordingtransmission or reproduction of sound or images; mechanisms for coin-operated apparatus; cash registerscalculating machinesdata processing equipment and computers; fire-extinguishing apparatus; contact lenses; optical lenses
Classe 10
Surgical apparatus and instruments; surgical apparatus and instruments for use in ophthalmic surgery; medical apparatus and instruments for use in the surgical implantation of intraocular lenses; veterinary apparatus and instruments for use in the surgical implantation of intraocular lenses; artificial limbseyes and teeth and artificial lenses for implantation in the eye; suture materials; intraocular lenses; intraocular lenses for surgical implantation; lensesintraocular prostheses for surgical implantation; intraocular prostheseslenses for surgical implantation; suture needles; needles for medical purposes; intraocular injection devices and intraocular injection devices preloaded with intraocular lens; injection devices for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/05/2022
FIMP
FINAL DISPOSITION PROCESSED
18/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
30/11/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
24/10/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
21/09/2021
APET
ASSIGNED TO PETITION STAFF
16/09/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/09/2021
EXPT
EXPARTE APPEAL TERMINATED
16/07/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/07/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/06/2021
PUBO
PUBLISHED FOR OPPOSITION
15/06/2021
GPNX
NOTIFICATION PROCESSED BY IB
13/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/06/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/06/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/05/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/05/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/05/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/05/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/05/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2021
ALIE
ASSIGNED TO LIE
28/04/2021
EXPI
EX PARTE APPEAL-INSTITUTED
23/04/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
23/04/2021
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
23/04/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/04/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/10/2020
GNFR
FINAL REFUSAL E-MAILED
23/10/2020
CNFR
FINAL REFUSAL WRITTEN
23/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/09/2020
ALIE
ASSIGNED TO LIE
16/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/08/2020
RFNT
REFUSAL PROCESSED BY IB
13/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/02/2020
RFRR
REFUSAL PROCESSED BY MPU
24/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/01/2020
CNRT
NON-FINAL ACTION WRITTEN
27/01/2020
DOCK
ASSIGNED TO EXAMINER
15/01/2020
MAFR
APPLICATION FILING RECEIPT MAILED
14/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIVINEX IMPRESS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.